Analyst Hints & Ratings — November 10, 2026 — Midday Update — Last 24 Hours (Pacific Time)

Executive Summary

Analyst activity over the past 24 hours skewed broadly mixed-to-bearish, with price target cuts outnumbering raises and several notable downgrades across tech, biotech, and crypto-adjacent names. The most dominant firms by volume were Jefferies, Raymond James, TD Cowen, Stifel, Needham, and Cantor Fitzgerald — the latter launching a sweeping retail/apparel coverage initiation. Key themes driving the session: GTA VI pre-launch enthusiasm lifting Take-Two Interactive to near-consensus Buy territory, Ionis Pharmaceuticals facing a multi-firm target slashing on a slow drug launch, and The Trade Desk receiving broad upward revisions following strong Q3 results.

Analyst Action Breakdown

Net Sentiment: Mixed — PT raises and cuts are nearly perfectly balanced at ~72 each. Upgrades and downgrades are also roughly even. The session reflects a post-earnings recalibration environment rather than a directional market call. Bullish pockets exist in gaming (Take-Two), programmatic advertising (Trade Desk), and select biotech; bearish pressure is concentrated in hydrogen energy, quantum bookings, pharma launches, and crypto miners.

Top Analyst Calls

🔴 Wells Fargo → Nvidia (NVDA) — PT Cut to $300 from $315, maintains Overweight

• Rationale: CEO investigation concerns prompted a modest but symbolically notable trim from one of the Street's most-watched chips names.

🟢 Jefferies → Riot Platforms (RIOT) — Upgraded to Buy from Hold, PT raised to $28 from $13

• Rationale: Corsicana data center asset value seen as significantly underappreciated by the market.

🟢 JPMorgan → Riot Platforms (RIOT) — PT raised to $28 from $22, maintains Overweight

• Rationale: Data center deal adds meaningful upside to the bitcoin miner's valuation thesis.

🔴 BofA → Wix.com (WIX) — Downgraded to Underperform from Buy, PT cut to $68

• Rationale: Revenue concerns drove a rare double-negative action — a downgrade plus a target cut — from a major firm.

🔴 Berenberg → DraftKings (DKNG) — Downgraded to Hold from Buy, PT cut to $20

• Rationale: Prediction market concerns are seen as a structural threat to the core sports betting business.

🟢 BTIG → Liquidia Technologies (LQDA) — PT raised to $87 from $70, maintains Buy

• Rationale: Strong demand dynamics support a notably aggressive target lift for this pulmonary hypertension play.

🔴 TD Cowen → Ionis Pharmaceuticals (IONS) — PT cut to $53 from $84, maintains Buy

• Rationale: Tryngolza launch miss triggered one of the largest single-firm target reductions of the session (~37% cut).

🔴 UBS → AST SpaceMobile (ASTS) — PT cut to $43 from $78, maintains Neutral

• Rationale: Scaling delays are materially denting the near-term commercial satellite connectivity story.

🟢 Goldman Sachs → Abercrombie & Fitch (ANF) — PT raised to $180 from $160, maintains Buy

• Rationale: Continued confidence in the retailer's brand momentum and earnings trajectory.

🔴 Jefferies → Peabody Energy (BTU) — Downgraded to Hold from Buy, PT cut to $18 from $30

• Rationale: Centurion mine delays remove a key near-term catalyst for the coal producer.

🟢 Needham → Nerdy (NRD) — PT raised to $8 from $2, maintains Buy

• Rationale: Cost efficiency improvements drove one of the session's largest percentage target increases.

🔴 UBS → Carlyle Group (CG) — Downgraded to Neutral from Buy, PT lowered

• Rationale: Growth concerns prompted UBS to step back from its bullish stance on the alternative asset manager.

🟢 Cantor Fitzgerald → Amer Sports (AS) — Initiated Overweight

• Rationale: Part of a broad retail/apparel coverage launch with a constructive view on the sports equipment brand.

🔴 Guggenheim → Zura Bio (ZURA) — PT slashed to $8 from $20, maintains Buy

• Rationale: Trial failure drove a 60% target reduction, though the firm maintained its Buy rating.

🟢 Jefferies → Alvotech (ALVO) — Initiated Buy, PT $9

• Rationale: Biosimilar pipeline seen as a compelling entry point for the Iceland-based biopharma.

Firm Activity Summary

Jefferies — 15 calls (8 bullish, 5 bearish, 2 neutral)

• LQDA ↑PT, SE ↓PT, TNGX ↑PT, BKSY ↓PT, KGS ↓PT, WIX ↑PT, TTWO reiterate Buy, MNDY ↓PT, PLNT reiterate Buy, TTD ↑PT, BTU downgrade, ALVO initiate Buy, CTY initiate Buy, MTRI initiate Buy, IAM initiate Buy

Raymond James — 11 calls (5 bullish, 4 bearish, 2 neutral)

• NRG ↓PT, SRRK reiterate Strong Buy, BDTX reiterate Outperform, SBH reiterate Outperform, CTRE ↓PT, CNH ↑PT, VERSK ↑PT, AHR ↑PT, UNIT ↓PT, SENS upgrade, IONS ↓PT

TD Cowen — 8 calls (4 bullish, 4 bearish)

• OFIX ↓PT, CSQR ↑PT, LCID ↓PT, AMG ↑PT, MNDY ↓PT, TTWO reiterate Buy, IONS ↓PT

Stifel — 10 calls (5 bullish, 5 bearish)

• BDTX ↑PT, BCAX ↓PT, KGS ↓PT, ECG ↓PT, DCH ↓PT, ONTO ↓PT, CPS ↓PT, FWRD ↑PT, WES ↓PT, MTRI initiate Buy, CTY initiate Buy

Needham — 11 calls (7 bullish, 3 bearish, 1 neutral)

• BW ↓PT, ACHR ↓PT, DOCGO ↓PT, CRMD ↑PT, SECZ ↑PT, TLS ↑PT, NRD ↑PT, BETR reiterate Buy, ONTO ↓PT, HIMS ↓PT, ZETA reiterate Buy, MNDY downgrade

Cantor Fitzgerald — 10 calls (6 bullish, 0 bearish, 4 neutral)

• NKE initiate Neutral, LULU initiate Neutral, AS initiate Overweight, TJX initiate Neutral, ASO initiate Overweight, ROST initiate Overweight, RL initiate Overweight, TPR initiate Overweight, DKS initiate Neutral, BURL initiate Neutral, ONON initiate Overweight, FIGS initiate Overweight

BofA (Bank of America) — 10 calls (3 bullish, 5 bearish, 2 neutral)

• WIX downgrade, MNDY ↓PT, TTWO reiterate Buy, NVDA reiterate Buy, SIRI reiterate Underperform, IONS ↓PT, ASTS ↓PT, LDI ↓PT, CSQR ↓PT, LRCX/MU/NVDA removed from US 1 list

Mizuho — 8 calls (5 bullish, 3 bearish)

• QBTS ↓PT, SENS ↑PT, GPN ↑PT, BTGO ↓PT, FOUR ↑PT, KGS ↓PT, WMT ↑PT, CEG reiterate Neutral

JPMorgan — 9 calls (5 bullish, 2 bearish, 2 neutral)

• RIOT ↑PT, TTWO reiterate Overweight, TNGX ↑PT, CEVA ↓PT, HIMS ↓PT, PM reinstate Neutral, FIX initiate Overweight, EME initiate Neutral, BTI reinstate Overweight, STRL initiate Overweight, OEC upgrade Neutral

UBS — 7 calls (3 bullish, 3 bearish, 1 neutral)

• CMI ↓PT, ASTS ↓PT, TTWO ↓PT, TTD ↑PT, FSLR ↓PT, CG downgrade, SCCO upgrade Neutral, MSDL upgrade Buy

Piper Sandler — 7 calls (4 bullish, 2 bearish, 1 neutral)

• CTEV ↑PT, ARWR reiterate Overweight, TTWO reiterate Overweight, IMNM ↓PT, VRTS ↑PT, CRSP reiterate Overweight, RKLB ↓PT

Truist — 8 calls (5 bullish, 2 bearish, 1 neutral)

• CNH ↓PT, WFC reiterate Buy, AVY reiterate Buy, RDNT reiterate Buy, FISV ↑PT, TOST ↑PT, HIMS reiterate Hold, CATX ↓PT, ZETA ↑PT, TTD ↑PT

KeyBanc — 7 calls (5 bullish, 1 bearish, 1 neutral)

• SGI ↓PT, RDNT ↑PT, ZETA reiterate Overweight, RKLB reiterate Overweight, RELY reiterate Overweight, ORCL reiterate Overweight, Starlink note

Citizens — 8 calls (6 bullish, 1 bearish, 1 neutral)

• CRMD reiterate Outperform, CORZ reiterate Outperform, VIA ↑PT, BCAX reiterate Outperform, AURA reiterate Outperform, RLGT ↑PT, Skydance ↓PT, ATLC ↑PT

Freedom Broker — 5 calls (2 bullish, 2 bearish, 1 neutral)

• SELF ↓PT, CLYM ↑PT, COST downgrade Hold, QCOM downgrade Hold, DXPE upgrade Buy

Rosenblatt — 5 calls (2 bullish, 3 bearish)

• BTGO ↓PT, PUBM ↑PT, MARA ↓PT, LINC ↓PT, TTD ↑PT

Bernstein — 4 calls (3 bullish, 0 bearish, 1 neutral)

• CSQR ↑PT, CNH ↑PT, LOW ↑PT, FERG reiterate Outperform

RBC Capital — 6 calls (4 bullish, 1 bearish, 1 neutral)

• TTD ↑PT, MSFT reiterate Outperform, EPC reiterate Outperform, AHR ↑PT, IONS ↓PT, FERG ↑PT, EVGO downgrade

BMO Capital — 6 calls (4 bullish, 0 bearish, 2 neutral)

• CSQR ↑PT, WMT ↑PT, CATX reiterate Outperform, TTD ↑PT, TTWO reiterate Outperform, ONON reiterate Market Perform

Wells Fargo — 5 calls (2 bullish, 3 bearish)

• NVDA ↓PT, EE ↑PT, IONS ↓PT, KKR ↑PT, MAIN ↓PT

Sector Trends

Technology & Software saw a bifurcated session. The Trade Desk (TTD) was the standout winner, receiving simultaneous target raises from UBS, Susquehanna, Truist, Jefferies, Scotiabank, BMO, and RBC — all citing strong Q3 results and improving advertiser budget trends. Conversely, monday.com (MNDY) faced coordinated cuts from BofA, TD Cowen, and Jefferies on soft guidance, and Needham outright downgraded the stock. Wix.com received a rare double-negative from BofA (downgrade + cut) while Jefferies went the other direction with a raise — a notable divergence. Nvidia drew attention with Wells Fargo trimming its target on CEO investigation concerns, though BofA held firm at $350 with a Buy.

Biotech & Pharma was the most active sector by volume, with a clear split between winners and losers. Ionis Pharmaceuticals (IONS) was the session's most-cut stock, with BofA, Wells Fargo, RBC, TD Cowen, and Raymond James all slashing targets on a slow Tryngolza launch — cuts ranging from ~$25 to ~$41 per share. On the bullish side, Liquidia (LQDA) received dual raises from BTIG and Jefferies on strong demand, Tango Therapeutics got lifts from both JPMorgan and Jefferies, and multiple firms initiated City Therapeutics and Mentari Therapeutics with Buy ratings. Black Diamond Therapeutics (BDTX) saw Stifel nearly double its target on trial progress.

Gaming, Crypto & Space each had defining narratives. Take-Two Interactive (TTWO) achieved rare near-unanimous bullish consensus ahead of GTA VI, with Buy/Overweight reiterations from JPMorgan ($310), BofA ($330), Jefferies ($300), Piper Sandler ($290), BMO ($285), TD Cowen ($284), Oppenheimer ($280), and BTIG ($262) — the spread in targets reflects differing GTA VI revenue assumptions rather than directional disagreement. Crypto miners MARA Holdings and Galaxy Digital faced cuts on bitcoin weakness and data center uncertainty. AST SpaceMobile (ASTS) was hit by both UBS and BofA on scaling delays, while Berenberg held its $92 Buy — another sharp divergence. Rocket Lab saw Piper Sandler cut aggressively on Neutron uncertainty while KeyBanc stood firm at $100.

Market Implications

The session's near-perfect balance between PT raises and cuts signals a market in active recalibration mode — analysts are digesting Q3 earnings results and resetting expectations rather than making broad directional bets. The most actionable signal for investors may be the Trade Desk consensus upgrade cycle: seven firms raised targets simultaneously, suggesting the programmatic advertising recovery is becoming a consensus view rather than a contrarian one. Similarly, Take-Two's near-universal bullish wall ahead of GTA VI represents one of the strongest analyst consensus clusters of the year in gaming.

The Ionis Pharmaceuticals pile-on is a cautionary signal for biotech investors: when five major firms cut targets in a single session on a drug launch miss, it often precedes further downward estimate revisions as the commercial trajectory becomes clearer. The AST SpaceMobile divergence — UBS and BofA cutting aggressively while Berenberg holds a $92 Buy — is a high-conviction disagreement worth monitoring, as it hinges entirely on satellite scaling execution timelines.

Cantor Fitzgerald's broad retail/apparel initiation sweep (10+ names) is notable for its tilt: Overweight on Ralph Lauren, Tapestry, Ross Stores, Amer Sports, Academy Sports, On Holding, and Figs — but only Neutral on Nike, Lululemon, TJX, Dick's, and Burlington. This suggests Cantor sees better risk/reward in value-oriented and brand-momentum names versus premium athleisure and off-price giants at current valuations.

Key Takeaways

• 🟢 Take-Two Interactive (TTWO) — Near-unanimous Buy wall from 8+ firms ahead of GTA VI; price targets range $262–$330, reflecting the most bullish analyst consensus of the session.
• 🔴 Ionis Pharmaceuticals (IONS) — Five firms cut targets in a single session (BofA to $63, Wells Fargo to $80, RBC to $60, TD Cowen to $53, Raymond James to $54) on Tryngolza launch miss — one of the day's clearest bearish consensus signals.
• 🟢 The Trade Desk (TTD) — Seven firms raised price targets on strong Q3 results; UBS led with a raise to $19, signaling a programmatic ad recovery is becoming consensus.
• 🔴 Wix.com (WIX) — BofA delivered a rare double-negative (downgrade to Underperform + PT cut to $68) while Jefferies raised to $85 — a high-conviction split worth watching.
• 🟢 Riot Platforms (RIOT) — Jefferies upgraded to Buy with a target doubling to $28 from $13 on Corsicana data center value; JPMorgan also raised to $28.
• 🔴 AST SpaceMobile (ASTS) — UBS cut to $43 from $78 and BofA cut to $45 from $80 on scaling delays; Berenberg holds firm at $92 Buy — a major analyst divergence.
• 🔴 DraftKings (DKNG) — Berenberg downgraded to Hold from Buy on prediction market structural concerns; a notable sentiment shift for the sports betting leader.
• 🟢 Liquidia Technologies (LQDA) — BTIG raised to $87 from $70 and Jefferies raised to $62 from $55, both maintaining Buy — strong demand driving dual upgrades in one session.
• 🔴 Peabody Energy (BTU) — Jefferies downgraded to Hold from Buy, cutting target to $18 from $30 on Centurion mine delays — a significant catalyst removal.
• 🔴 monday.com (MNDY) — Needham downgraded to Hold, BofA cut to $90, TD Cowen cut to $95, Jefferies cut to $90 — broad-based bearish reset on soft guidance.
• 🟢 Nerdy (NRD) — Needham raised PT to $8 from $2 (300% increase) on cost efficiency — one of the session's largest percentage target moves.
• 🔴 Zura Bio (ZURA) — Guggenheim slashed PT to $8 from $20 on trial failure, a 60% cut; firm maintained Buy, suggesting residual pipeline value.
• 🟢 American Healthcare REIT (AHR) — Both Raymond James (to $72) and RBC (to $66) raised targets on growth outlook — quiet but consistent bullish signal in healthcare real estate.
• 🔴 Carlyle Group (CG) — UBS downgraded to Neutral from Buy on growth concerns — a notable shift for a major alternative asset manager.
• 🟢 Cantor Fitzgerald retail sweep — Initiated Overweight on Ralph Lauren, Tapestry, Ross Stores, Amer Sports, Academy Sports, On Holding, and Figs; Neutral on Nike, Lululemon, TJX, Dick's, Burlington — value/momentum over premium at current prices.
• 🔴 Plug Power (PLUG) — Craig-Hallum cut to $3 from $5 on timing uncertainty; Oppenheimer reiterated Perform — hydrogen story remains in a wait-and-see mode.
• 🟢 Black Diamond Therapeutics (BDTX) — Stifel nearly doubled its target to $14 from $8 on trial progress; Raymond James reiterated Outperform at $11 — clinical momentum building.
• 🔴 Hims & Hers (HIMS) — JPMorgan cut to $24 from $32 and Needham cut to $32 from $42 on subscriber decline; Canaccord held firm at $40 Buy — divergence on growth trajectory.
• 🟢 Walmart (WMT) — Both BMO (to $136) and Mizuho (to $135) raised targets on business/marketplace strength — blue-chip retail remains a consensus long.
• 🔴 EVgo (EVGO) — RBC downgraded to Sector Perform and Roth/MKM downgraded to Neutral on slower deployment and take-private offer concerns — dual downgrade is a meaningful sentiment shift for EV charging.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Analyst ratings and price targets reflect individual firm opinions and can change at any time. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/